PharmaCyte Biotech, Inc.
PMCB
Last
$0.40
Day
+2.2%
1y
-60.7%
5y
-87.0%
52w
-73.7%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
0.43
EMA 50
0.49
EMA 200
0.68
20d high
-20.5%
5y high
-87.7%
5y range
2th
Positions held
Your positionsPMCB isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-15
Hold
avoid
Signal
Strong Sell
Target
$0.46
Stop
$0.35
Stop distance
13.4%
Target vs last
+13.8%
Fundamentals
| Market cap | $4.27M | Enterprise value | -$24.36M | Trailing P/E | — | Forward P/E | -1.05 |
| PEG | — | Price / book | 0.15 | Beta | 0.68 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -44.0% | ROA | -8.3% | Debt / equity | — |
| Current ratio | 40.30 | Free cash flow | $2.57M | Analyst recommendation | none | Mean target | — |
| 52w high | $1.51 | 52w low | $0.33 |
Quarterly
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$5.1M | -$4.4M | $0.7M | -$7.4M | -$8.4M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.0M | -$1.0M | -$2.1M | -$1.4M | -$0.8M | — |
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$19.4M | $30.7M | $0.3M | -$4.3M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$5.3M | -$4.4M | -$6.5M | -$6.5M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsPMCB · daily-13.3% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin